Trial · NCT02290444
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline on the Symbol Digit Modalities Test (SDMT) | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Correct | MEAN |
| PRIMARY | Timed 25-foot Walk | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Seconds | MEAN |
| PRIMARY | Change From Baseline on the Paced Auditory Serial Addition Test (PASAT) | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Correct | MEAN |
| PRIMARY | Change From Baseline on the Brief Visuospatial Memory Test-Revised (BVMT-R) | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Learning Score | MEAN |
| PRIMARY | Change From Baseline on the California Verbal Learning Test, Second Edition (CVLT-II) | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Learning Score | MEAN |
| SECONDARY | Change From Baseline on the Expanded Disability Status Scale (EDSS). | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Score | MEDIAN |
| SECONDARY | Change From Baseline on the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Score | MEAN |
| SECONDARY | Change From Baseline on the Beck Depression Inventory-Fast Screen (BDI-FS) | Day 0 and Day 90 | Total Score | MEAN | |
| SECONDARY | Change From Baseline on the Fatigue Severity Scale (FSS) | Day 0 and Day 90 | The sample used for final analysis was smaller than the total enrolled (see Participant Flow) because participants were excluded from the final analysis due to (1) withdrawal prior to follow-up, (2) occasional missing data from one or more timepoints, and (3) to optimize matching of the groups based on demographic characteristics. | Total Score | MEAN |
| OTHER_PRE_SPECIFIED | Incidence of Adverse Events | Up to 3 months | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Concurrent Medications | Up to 3 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02290444/outcomes